Showing results (11-20 of 210) with videos related to

Sort By:
Pageof 21
Clinical and Experimental Immunology|July 1, 1994
Polyclonal intravenous immune globulin for prevention and treatment of infections in critically ill patientsA Cometta, J D Baumgartner, M P Glauser
Progress in Clinical and Biological Research|January 1, 1991
Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shockT Calandra, J D Baumgartner, M P Glauser
Schweizerische Medizinische Wochenschrift|January 2, 2001
[Evaluation of antibiotic prophylaxis in neutropenic patients with hematologic malignancies]P Delarive, J D Baumgartner, M P Glauser, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 1994
Pathogenesis and potential strategies for prevention and treatment of septic shock: an updateM P Glauser, D Heumann, J D Baumgartner, et al.
The Journal of Infectious Diseases|April 1, 1991
Antibodies to lipopolysaccharides after immunization of humans with the rough mutant Escherichia coli J5J D Baumgartner, D Heumann, T Calandra, et al.
The Journal of Infectious Diseases|April 1, 1991
Antibodies to core lipopolysaccharide determinants: absence of cross-reactivity with heterologous lipopolysaccharidesD Heumann, J D Baumgartner, H Jacot-Guillarmod, et al.
The American Journal of Medicine|July 1, 1991
High circulating levels of interleukin-6 in patients with septic shock: evolution during sepsis, prognostic value, and interplay with other cytokines. The Swiss-Dutch J5 Immunoglobulin Study GroupT Calandra, J Gerain, D Heumann, et al.
The Journal of Infectious Diseases|June 1, 1993
Competition between bactericidal/permeability-increasing protein and lipopolysaccharide-binding protein for lipopolysaccharide binding to monocytesD Heumann, P Gallay, S Betz-Corradin, et al.
The Journal of Infectious Diseases|July 1, 1987
Demonstration of cross-reactive antibodies to smooth gram-negative bacteria in antiserum to Escherichia coli J5J D Baumgartner, T X O'Brien, T N Kirkland, et al.
The Journal of Experimental Medicine|March 1, 1990
Association between protective efficacy of anti-lipopolysaccharide (LPS) antibodies and suppression of LPS-induced tumor necrosis factor alpha and interleukin 6. Comparison of O side chain-specific antibodies with core LPS antibodiesJ D Baumgartner, D Heumann, J Gerain, et al.
Pageof 21